It’s an exciting time in diabetes with several technologies available on the horizon. Advances in technology offer new choices for insulin pumps, connected “smart” pens, continuous glucose monitors (CGM) and automated insulin delivery systems. In this touchENDOCRINOLOGY interview, Dr Diana Isaacs (Endocrine Clinical Pharmacy Specialist, Cleveland Clinic, Cleveland, OH, USA) discusses these technologies and explores how they have shown dramatic effects on glycaemic management and time in range.
The abstract entitled: ‘Diabetes Technology Update and Impact on Time in Range‘ was presented at the Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, 12-15 Aug, 2022.
Questions:
- Why is time in range so important in diabetes management? (0:15)
- Could you give us a brief overview of the latest advances in insulin pumps, connected “smart” pens, continuous glucose monitors and automated insulin delivery systems? (1:18)
- What clinical evidence supports the use of these new technologies? (4:44)
- How can we optimise the use of these technologies to maximise the impact on timein range? (5:43)
Disclosures: Diana Isaacs is a consultant for Eli Lilly, and Sanofi; and is a speaker’s bureau participant for Dexcom, Abbott, Bayer, Insulet, Medtronic, Cequr, and Novo Nordisk.
Support: Interview supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Recorded as a highlight of ADCES 2022
Click here for more related content.
